DRWF Trustee Dr Shivani Misra awarded for pioneering research on diabetes risk in South Asian populations
In addition to the primary Precision Diabetes Medicine Award presented to Dr Misra, two distinguished researchers have been selected as runners-up, each receiving grants of DKK 500,000 for their research projects.
Professor Cyrielle Caussy from Lyon University Hospital Center in France leads the research project Type 2 DIAbeTes with NAFLD: innOvative biomarkers of disease progressioN and clInical outComes, aiming to explore the potential of initial non-invasive biomarkers to identify which type 2 diabetes patients are at risk for progressing non-alcoholic fatty liver disease.
Professor Eran Elinav from the Weizmann Institute of Science in Israel is the second runner-up, with a project titled Decoding the Molecular Microbiome-driven Mechanisms of Rapid Post-bariatric Improvement in Diabetes. His research project aims to uncover the mechanisms behind the rapid improvement in glucose regulation seen in individuals with type 2 diabetes following bariatric surgery.
The Precision Diabetes Medicine Award was established in 2021 and has been awarded annually since then, marking the 100th anniversary of the discovery of insulin in 1921, its first use in humans in 1922, and its first Nobel Prize recognition in 1923. This year’s award is to be the last.
Martin Ridderstråle, Senior Vice President and head of Medical Science at the Novo Nordisk Foundation, said: “The field has advanced hugely in the last few years, with this award contributing by supporting vital research and raising awareness of the transformative potential of precision diabetes medicine.
“Although the award is ending, the Novo Nordisk Foundation remains committed to realising that potential through bringing scientists together around a common terminology and agenda, as well as the translational work that goes on at the research and clinical centers and other strategic initiatives.”
Professor Stehouwer added: “Over the last three years, the EFSD and Novo Nordisk Foundation Precision Diabetes Medicine Award has supported a number of promising novel approaches in precision diabetes medicine. The work of the awardees has contributed to more effective and personalized management of diabetes, which can ultimately improve the overall quality of life for people with this chronic condition.”
The awardees are invited to deliver an award lecture at the Future of Precision Medicine Symposium 2023, scheduled for 9-10 November 2023 at the Novo Nordisk Foundation in Copenhagen. Additionally, they will be able to contribute an article from their perspective to Diabetologia.
Dr Misra recently helped develop the new NHS programme T2Day: Type 2 Diabetes in the Young programme, created to support a rising number of 18 to 40-year-olds being diagnosed with the condition. Read more here.
Dr Misra was the recipient of a DRWF 3-year Clinical Fellowship in 2012, and won the 2017 International Diabetes Federation Europe Prize for young researcher for her MY DIABETES study.
The study focused on classifying types of diabetes in people with young-onset diabetes from different ethnic groups, to investigate whether ethnicity has an impact on diabetes presentation and type. One of the key findings from the study was the discovery that genetic forms of diabetes are being misdiagnosed in people from ethnic minority groups.
In 2018, Dr Misra was named in the Evening Standard 1000 health influencers for her work on the misdiagnosis of thousands of patients due to misconceptions about the role of ethnicity and diabetes. She also received the Outstanding Educator Award at the 2021 Quality in Care Diabetes awards for her MY DIABETES study.
Read more about 25 years of DRWF research
Read more about type 2 diabetes
I would like to make a regular donation of
I would like to make a single donation of